3 ms·
The greater cause for concern is the fact that the whistleblower submitted a report to the FDA which was ignored, and was then fired in retaliation. That sugges
by AndrewBissell 5y ago
The greater cause for concern is the fact that the whistleblower submitted a report to the FDA which was ignored, and was then fired in retaliation. That suggests the possible presence of systemic weaknesses with much broader impact beyond Ventavia.
The inability to swab 477 trial participants to test for SARS-CoV-2 infection is also pretty bad given that confirmed symptomatic cases of COVID were the metric used to establish the efficacy numbers in the trial.
- sterlind 5y agodid someone in the FDA disclose the whistleblower's identity to Ventavia? or did they figure it out on their own? retaliation either way, but I didn't see any evidence of conspiracy in the article.
- AndrewBissell 5y agoYeah the article doesn't make it clear. In my own reading I had assumed Ventavia figured it out on its own.
- mewpmewp2 5y agoThere's countless of other questions and concerns this article brings up in my view. You must really give benefit of the doubt to Pfizer to not expect there to be something wrong with the final data.